{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:16:44Z","timestamp":1790363804509,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.clinre.2018.08.006","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T02:28:32Z","timestamp":1536805712000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease"],"prefix":"10.1016","volume":"43","author":[{"given":"Maria Cristina","family":"Leoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linde","family":"Amelung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faydra I.","family":"Lieveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"van den Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep","family":"de Bruijne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop E.","family":"Arends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel-Peter","family":"van Erpecum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel J.","family":"van Erpecum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2018.08.006_bib0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12072-017-9830-1","article-title":"Primary biliary cholangitis: a comprehensive overview","volume":"11","author":"Lleo","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.clinre.2018.08.006_bib0010","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.08.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2018.08.006_bib0020","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.510300603","article-title":"Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial","volume":"30","author":"Czaja","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2018.08.006_bib0025","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2018.08.006_bib0030","first-page":"239","article-title":"Relationship of blood pressure control to adherence with anti-hypertensive monotherapy in 13 managed care organizations","volume":"12","author":"Bramley","year":"2006","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.clinre.2018.08.006_bib0035","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/HYPERTENSIONAHA.110.153817","article-title":"Monitoring adherence to medication by measuring change in blood pressure","volume":"56","author":"Hayen","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.clinre.2018.08.006_bib0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/QAI.0b013e318199072e","article-title":"Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa","volume":"51","author":"Nachega","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.clinre.2018.08.006_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":"Adherence to protease inhibitor therapy and outcomes in patients with HIV infection","volume":"133","author":"Paterson","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2018.08.006_bib0050","first-page":"31","article-title":"Persistence with treatment for hypertension in actual practice","volume":"160","author":"Caro","year":"1999","journal-title":"CMAJ"},{"key":"10.1016\/j.clinre.2018.08.006_bib0055","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2125.2005.02355.x","article-title":"Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention","volume":"59","author":"Perreault","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinre.2018.08.006_bib0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.dld.2015.03.024","article-title":"Real life adherence of chronic hepatitis B patients to entecavir treatment","volume":"47","author":"van Vlerken","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2018.08.006_bib0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.clinre.2015.12.014","article-title":"Adherence to ribavirin in chronic hepatitis C patients on antiviral treatment: results from a randomized controlled trial using real-time medication monitoring","volume":"40","author":"van Vlerken","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2018.08.006_bib0070","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1478-3231.2011.02461.x","article-title":"Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study","volume":"31","author":"Marcellin","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2018.08.006_bib0075","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.clinre.2018.08.006_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","article-title":"The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","year":"1999","journal-title":"Psychol Health"},{"key":"10.1016\/j.clinre.2018.08.006_bib0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.clinre.2018.08.006_bib0090","unstructured":"https:\/\/www.ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf."},{"key":"10.1016\/j.clinre.2018.08.006_bib0095","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ibd.20846","article-title":"Patients\u02bc attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease","volume":"15","author":"Horne","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clinre.2018.08.006_bib0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.238","article-title":"Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication","volume":"3","author":"Aikens","year":"2005","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.clinre.2018.08.006_bib0105","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1665-2681(19)31000-2","article-title":"Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review","volume":"12","author":"Lieveld","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinre.2018.08.006_bib0110","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijmedinf.2012.05.005","article-title":"SMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitored","volume":"81","author":"Vervloet","year":"2012","journal-title":"Int J Med Inform"},{"issue":"5","key":"10.1016\/j.clinre.2018.08.006_bib0115","article-title":"Improving medication adherence in diabetes type 2 patients through real time medication monitoring: a randomised controlled trial to evaluate the effect of monitoring patients\u2019 medication use combined with short message service (SMS) reminders","volume":"11","author":"Vervloet","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.clinre.2018.08.006_bib0120","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1365-2036.2003.01792.x","article-title":"Systematic review: ursodeoxycholic acid\u2009\u2013\u2009adverse effects and drug interactions","volume":"18","author":"Hempfling","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2018.08.006_bib0125","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/QAI.0b013e31806910e3","article-title":"Patients\u2019 perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework","volume":"45","author":"Horne","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.clinre.2018.08.006_bib0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychores.2007.07.016","article-title":"Beliefs about medicines predict refill adherence to inhaled corticosteroids","volume":"64","author":"Menckeberg","year":"2008","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.clinre.2018.08.006_bib0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1521\/aeap.2014.26.6.521","article-title":"Adherence to antiretroviral therapy among HIV-infected adults in the United States","volume":"26","author":"Beer","year":"2014","journal-title":"AIDS Educ Prev"},{"key":"10.1016\/j.clinre.2018.08.006_bib0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhep.2010.06.016","article-title":"Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B","volume":"54","author":"Chotiyaputta","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2018.08.006_bib0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0091270004274433","article-title":"Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models","volume":"45","author":"Vrijens","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinre.2018.08.006_bib0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/096228029900800305","article-title":"The impact of compliance in pharmacokinetic studies","volume":"8","author":"Vrijens","year":"1999","journal-title":"Stat Methods Med Res"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118301700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740118301700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:26:45Z","timestamp":1761895605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740118301700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2210740118301700"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2018.08.006","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to ursodeoxycholic acid therapy in patients with cholestatic and autoimmune liver disease","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2018.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}